​

Oncolytics Biotech Ownership | Who Owns Oncolytics Biotech?

OverviewForecastFinancialsChartTranscripts

Oncolytics Biotech Ownership Summary

Oncolytics Biotech is owned by 3.13% institutional investors, 2.78% insiders, and 94.10% retail investors. Renaissance is the largest institutional shareholder, holding 0.75% of ONCY shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in Oncolytics Biotech shares.

ONCY Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOncolytics Biotech3.13%2.78%94.10%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Renaissance715.84K0.75%$607.60K
Sandbox financial partners400.00K0.42%$339.52K
Seeds investor258.31K0.27%$263.47K
Tocqueville asset management149.00K0.16%$126.47K
Everhart financial group138.16K0.14%$117.27K
Quadrature capital106.08K0.12%$146.38K
Xtx topco109.76K0.11%$93.16K
Doliver advisors, lp100.00K0.10%$84.88K
Lpl financial78.90K0.08%$66.97K
Franklin resources69.84K0.07%$71.31K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sandbox financial partners400.00K0.10%$339.52K
Seeds investor258.31K0.04%$263.47K
Ball & co wealth management38.25K0.03%$32.00K
Doliver advisors, lp100.00K0.02%$84.88K
Security national bank of sioux city iowa /ia/33.26K0.02%$28.23K
Everhart financial group138.16K0.01%$117.27K
Scientech research18.20K0.01%$25.49K
Vantage point financial29.74K0.01%$25.25K
Headinvest44.70K0.01%$37.94K
Seacrest wealth management32.00K0.00%$27.16K

Top Buyers

HolderShares% AssetsChange
Renaissance715.84K0.00%715.84K
Sandbox financial partners400.00K0.10%400.00K
Everhart financial group138.16K0.01%138.16K
Quadrature capital106.08K0.00%106.08K
Doliver advisors, lp100.00K0.02%100.00K

Top Sellers

HolderShares% AssetsChange
Morgan stanley27.99K--398.53K
Marshall wace, llp---262.17K
International assets investment management---208.15K
Goldman sachs group---169.90K
Connective capital management---150.34K

New Positions

HolderShares% AssetsChangeValue
Renaissance715.84K0.00%715.84K$607.60K
Sandbox financial partners400.00K0.10%400.00K$339.52K
Everhart financial group138.16K0.01%138.16K$117.27K
Quadrature capital106.08K0.00%106.08K$146.38K
Doliver advisors, lp100.00K0.02%100.00K$84.88K

Sold Out

HolderChange
Russell investments group-1.00
Citigroup-1.00
Wolff wiese magana-31.00
Pacifica partners-100.00
Ifp advisors-100.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202656-8.20%2,996,3217.11%341.00%3036.36%3-40.00%
Dec 31, 202536-35.71%1,385,405-50.88%114.24%9-52.63%2-71.43%
Sep 30, 202530-43.40%910,881-32.37%139.52%5-76.19%2-60.00%
Jun 30, 20255512.24%1,492,51810.47%155.94%239.52%5-28.57%
Mar 31, 2025508.70%1,365,5173.85%160.09%22-8.33%7-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index66.94K0.06%-
Vifag 2002 SICAV30.00K0.04%-

Recent Insider Transactions

DateNameRoleActivityValue
Mar 11, 2026Parsons James T.-Buy$10.30K
Mar 12, 2026Kelly Jared Chief Executive OfficerBuy$4.85K
Feb 12, 2026Kelly Jared Chief Executive OfficerBuy$24.84K
Feb 11, 2026Kelly Jared Chief Executive OfficerBuy$4.68K
Feb 12, 2026Look Kirk Chief Financial OfficerBuy$10.10K

Insider Transactions Trends

DateBuySell
2026 Q114-

ONCY Ownership FAQ

Who Owns Oncolytics Biotech?

Oncolytics Biotech shareholders are primarily institutional investors at 3.13%, followed by 2.78% insiders and 94.09% retail investors. The average institutional ownership in Oncolytics Biotech's industry, Biotech Stocks , is 35.75%, which Oncolytics Biotech falls below.

Who owns the most shares of Oncolytics Biotech?

Oncolytics Biotech’s largest shareholders are Renaissance (715.84K shares, 0.75%), Sandbox financial partners (400K shares, 0.42%), and Seeds investor (258.31K shares, 0.27%). Together, they hold 1.43% of Oncolytics Biotech’s total shares outstanding.

Does Blackrock own Oncolytics Biotech?

BlackRock is not among the top 10 institutional shareholders of Oncolytics Biotech.

Who is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested?

Sandbox financial partners is Oncolytics Biotech’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 400K Oncolytics Biotech shares, valued at 339.52K$.

Who is the top mutual fund holder of Oncolytics Biotech shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Oncolytics Biotech shares, with 0.06% of its total shares outstanding invested in 66.94K Oncolytics Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools